scholarly journals Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?

Author(s):  
Cuneyt Salturk ◽  
Zuhal Karakurt ◽  
Huriye Takir ◽  
Gokay Gungor ◽  
Feyza Kargin ◽  
...  



2006 ◽  
Vol 34 (12) ◽  
pp. 2946-2951 ◽  
Author(s):  
Fran A. Priestap ◽  
Claudio M. Martin




2014 ◽  
Vol 9 (4) ◽  
pp. 403-408 ◽  
Author(s):  
Cengizhan Sezgi ◽  
Mahsuk Taylan ◽  
Halide Kaya ◽  
Hadice Selimoglu Sen ◽  
Ozlem Abakay ◽  
...  


2004 ◽  
Vol 25 (12) ◽  
pp. 1090-1096 ◽  
Author(s):  
Stéphane Hugonnet ◽  
Philippe Eggimann ◽  
François Borst ◽  
Patrice Maricot ◽  
Jean-Claude Chevrolet ◽  
...  

AbstractObjective:To assess the effect of ventilator-associated pneumonia on resource utilization, morbidity, and mortality.Design:Retrospective matched cohort study based on prospectively collected data.Setting:Medical intensive care unit of a university teaching hospital.Patients:Case-patients were all patients receiving mechanical ventilation for 48 hours or more who experienced an episode of ventilator-associated pneumonia. Control-patients were matched for number of discharge diagnoses, duration of mechanical support before the onset of pneumonia among case-patients, age, admission diagnosis, gender, and study period.Results:One hundred six cases of ventilator-associated pneumonia were identified in 452 patients receiving mechanical ventilation. The matching procedure selected 97 pairs. Length of stay in the intensive care unit and duration of mechanical ventilation were greater among case-patients by a mean of 7.2 days (P< .001) and 5.1 days (P< .001), respectively. Median costs were $24,727 (interquartile range, $18,348 to $39,703) among case-patients and $17,438 (interquartile range, $12,261 to $24,226) among control-patients (P< .001). The attributable mortality rate was 7.3% (P = .26). The attributable extra hospital stay was 10 days with an extra cost of $15,986 per episode of pneumonia.Conclusion:Ventilator-associated pneumonia negatively affects patient outcome and represents a significant burden on intensive care unit and hospital resources.



Critical Care ◽  
2012 ◽  
Vol 16 (5) ◽  
pp. R173 ◽  
Author(s):  
David JP O'Callaghan ◽  
Parveen Jayia ◽  
Eyston Vaughan-Huxley ◽  
Michael Gribbon ◽  
Maie Templeton ◽  
...  


Author(s):  
David A. Sotello Aviles ◽  
Walter C. Hellinger

Infection is a common complication in the intensive care unit (ICU). Furthermore, infection more than doubles the mortality rate in the ICU. Antibiotic resistance in Staphylococcus aureus, Enterococcus, Enterobacteriaceae, and fungal infection is among the most challenging issues in the ICU. In addition, critical illness affects antibiotic pharmacokinetics. Thus, implementation of strategies to prevent infection is of utmost importance to improve patient outcome.



Sign in / Sign up

Export Citation Format

Share Document